ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JORDAN KEMPKER M.D.

Internal Medicine

1,090

$74.9K

192
100 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $56

RICHARD KIM M.D., M.B.A.

Internal Medicine

1,084

$59.6K

181
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

HARITHA ARIKATLA MD

Internal Medicine

1,079

$36.5K

182
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

ROBERT CONEY MD

Internal Medicine

1,078

$71.9K

61
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $56

ANDRE LEWIS MD

Internal Medicine

1,069

$54.8K

342
253 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

MALCOLM TRAXLER MD

Internal Medicine

1,058

$64K

53
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

JULIET MAVROMATIS M.D.

Internal Medicine

1,050

$76.8K

40
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$73
Average prescription price

Avg: $56

DAVID SCURLOCK MD

Internal Medicine

1,049

$66.3K

84
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $56

PANKIL PATEL M.D.

Internal Medicine

1,045

$68.1K

68
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

YOHANNES BELACHEW M.D

Internal Medicine

1,044

$30.2K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$29
Average prescription price

Avg: $56

HIREN JOSHI

Internal Medicine

1,025

$49.1K

74
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

PRAVINKUMAR PATEL M.D.

Internal Medicine

1,023

$40.1K

64
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

DANIEL FRILINGOS M.D.

Internal Medicine

1,016

$63.5K

92
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $56

IFEYINWA ADIMORAH MD

Internal Medicine

1,014

$39.1K

148
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

BEVERLY SANDERS M.D.

Internal Medicine

994

$54.1K

130
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

CHRISTOPHER MIDDENDORF M.D.

Internal Medicine

993

$59.8K

80
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

AAZRUM SYED M.D.

Internal Medicine

988

$74K

115
95 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $56

DANIEL RILEY MD

Internal Medicine

988

$36.1K

373
289 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

AMY VARNER M.D.

Internal Medicine

987

$68.9K

119
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $56

RALPH AUSTIN M.D.

Internal Medicine

979

$29.7K

238
145 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $56

ERIC POWELL MD

Internal Medicine

974

$21.6K

408
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 26%

$22
Average prescription price

Avg: $56

ALICE WEI YOU MD

Internal Medicine

971

$28.8K

89
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $56

SOFIA ZAMAN M.D.

Internal Medicine

969

$37.7K

77
64 are 65+

34%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

ROBERT SHUMAN M.D.

Internal Medicine

963

$49.2K

129
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

DENISE CUBERO MD

Internal Medicine

958

$51K

109
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank